Roth Capital raised the firm's price target on Daktronics to $29 from $26 and keeps a Buy rating on the shares. Daktronics ended FY26 with strong momentum, highlighted by a record $839M in orders and a $356M backlog, reflecting effective execution of its transformation strategy focused on operational efficiency, disciplined cost management, and monetizing its integrated solutions portfolio, the analyst tells investors in a research note.
